Showing 1 to 10 of 11 Clinical Trials
|
CLINICAL TRIAL Trial No ClinicalTrials.gov ID |
Principal Investigator
Coordinator |
||
|---|---|---|---|
|
Multimodal PREhabilitation program for endometrial cancer patients. A feasibility study
PREPARE n.d.  Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Uterus Lining |
Dr. Vanessa Samouëlian France Gauthier 514-890-8000 poste 30921 |
|
ATARI: ATr Inhibitor in Combination With Olaparib in Gynaecological Cancers With ARId1A Loss
ATARI NCT04065269 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Ovary Uterus Lining |
Dr. Diane Provencher Lynda Abdelguerfi 514-890-8000 poste 30657 |
|
A Phase 3 Randomized, Open-label, Active-comparator Controlled Clinical Study of Pembrolizumab Versus Platinum Doublet Chemotherapy in Participants With Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma in the First-line Setting
KEYNOTE-C93 (GOG-3064/ENGOT-en15) NCT05173987 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Uterus Lining |
Dr. Vanessa Samouëlian France Gauthier 514-890-8000 poste 30921 |
|
A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial of Selinexor in Maintenance Therapy After Systemic Therapy for Patients With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma
XPORT-EC-042 NCT05611931 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Uterus Lining |
Dr. Vanessa Samouëlian Josée Tremblay 514-890-8000 poste 30637 |
|
A Phase 3 Randomized, Open-label, Active-comparator Controlled Clinical Study of Pembrolizumab Versus Platinum Doublet Chemotherapy in Participants With Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma in the First-line Setting
KEYNOTE-C93 (GOG-3064/ENGOT-en15) NCT05173987 Recruiting
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS
|
Uterus Lining |
Dr. Susie Lau |
|
A Phase II, Single-Arm Study of Giredestrant in Patients With Grade 1 Endometrial Cancer
EndomERA NCT05634499 Recruiting
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS
|
Uterus Lining |
Dr. Susie Lau Alessandra Figueiredo De Vasconcelos 514-340-8222 poste 26823 |
|
A Phase 3, Randomized, Double-Blind Study of Pembrolizumab Versus Placebo in Combination With Adjuvant Chemotherapy With or Without Radiotherapy for the Treatment of Newly Diagnosed High-Risk Endometrial Cancer After Surgery With Curative Intent
KEYNOTE-B21 / ENGOT-en11 / GOG-3053 NCT04634877 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Uterus Lining |
Dr. Lucy Gilbert Phuong-Nam (Nathalie) Nguyen 514-934-1934 poste 31975 |
|
A Phase 3 Randomized, Open-label, Active-comparator Controlled Clinical Study of Pembrolizumab Versus Platinum Doublet Chemotherapy in Participants With Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma in the First-line Setting
KEYNOTE-C93 (GOG-3064/ENGOT-en15) NCT05173987 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Uterus Lining |
Dr. Christine Lambert Dr. Lucy Gilbert Phuong-Nam (Nathalie) Nguyen 514-934-1934 poste 31975 |
|
A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial of Selinexor in Maintenance Therapy After Systemic Therapy for Patients With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma
XPORT-EC-042 NCT05611931 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Uterus Lining |
Dr. Lucy Gilbert Phuong-Nam (Nathalie) Nguyen 514-934-1934 poste 31975 |
|
A Phase II, Single-Arm Study of Giredestrant in Patients With Grade 1 Endometrial Cancer
EndomERA NCT05634499 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Uterus Lining |
Dr. à venir |
Groupe d'étude en oncologie du Québec